Search
for
Sort by
Research 211–240 of 1000+
- National scientific medical meeting 1996 abstracts
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Evaluation of acute, subacute oral toxicity and wound healing activity of mother plant and callus of Teucrium polium L. subsp. geyrii Maire from Algeria
- Modulation of Photoaging-Induced Cutaneous Elastin: Evaluation of Gene and Protein Expression of Markers Related to Elastogenesis Under Different Photoexposure Conditions
- Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
- Discovery of genes and proteins possibly regulating mean wool fibre diameter using cDNA microarray and proteomic approaches
- AVALIAÇÃO DO USO DE TELAS DIGITAIS POR CRIANÇAS E ADOLESCENTES EM TEMPOS DE PANDEMIA
- Herbal Shampoo Formulations Enriched with Phytoconstituents as Effective Alternatives to Ketoconazole: Comparative Physicochemical and Antifungal Evaluation Against Malassezia furfur
- Polarized microscopy in genetic hair disorders: case series
- Early skin seeding regulatory T cells modulate PPARγ-dependent skin pigmentation
- Unravelling the link between insulin resistance and androgen excess
- Pharmacologic interventions in aging hair
- Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars
- QUESTIONS OF TEACHING MEDICAL BIOCHEMISTRY AS PART OF AN INTEGRATED EDUCATIONAL PROGRAM IN A MEDICAL UNIVERSITY
- Sebaceous Gland, Hair Shaft, and Epidermal Barrier Abnormalities in Keratosis Pilaris with and without Filaggrin Deficiency
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Preparation and Evaluation of Herbal Hair Cream in The Treatment of Alopecia by using Jamalgota, Neem Oil, Amla, Hibiscus Oil and Aloe Vera
- Preparation and Evaluation of Herbal Hair Cream in The Treatment of Alopecia by using Jamalgota, Neem Oil, Amla, Hibiscus Oil and Aloe Vera
- Roota Hair Growth A Botanical Breakthrough for Stronger Fuller Hair
- Roota Hair Growth A Botanical Breakthrough for Stronger Fuller Hair
- Pathophysiology and Therapeutic Remodeling of Androgenetic Alopecia (Male Pattern Baldness) via Bio-Electric and Hydrodynamic Restoration
- Pathophysiology and Therapeutic Remodeling of Androgenetic Alopecia (Male Pattern Baldness) via Bio-Electric and Hydrodynamic Restoration
- Pathophysiology and Therapeutic Remodeling of Androgenetic Alopecia (Male Pattern Baldness) via Bio-Electric and Hydrodynamic Restoration
- Pathophysiology and Therapeutic Remodeling of Androgenetic Alopecia (Male Pattern Baldness) via Bio-Electric and Hydrodynamic Restoration
- A REVIEW ON HAIR CONDITION PROPERTIES OF VARIOUS MEDICINAL HERBS
- ALOE-VERA IN HAIR COSMETICS
- ALOE-VERA IN HAIR COSMETICS
- Integrative Nutritional Mechanisms of Keyora Lycopene 23 in 1 Man's Multi-Vitamin in Erectile Dysfunction, Male Infertility, Prostatic Disorders, and Metabolic Dysregulation